Case study
Claims Analytics to Shape Business Unit Size and Structure
Defining the Future of Rare Hematology
As a big pharma company prepared to launch a novel therapy for a rare hematological condition, they needed a deep understanding of their healthcare provider (HCP) and patient landscape. Akimbo Health was engaged to provide insights and design a business unit optimized for this unique market.
From Data to Actionable Insights
Akimbo’s work began with meticulous selection and analysis of claims data, creating a comprehensive view of the HCP universe, patient demographics, and treatment journeys. Using this foundation, Akimbo partnered with the client to define the size and structure of a new US business unit.
A Strategic Framework for Growth
The results gave the company a detailed understanding of their target audience and clear guidance on resource allocation. Armed with these insights, the client was able to plan hiring and resourcing strategies to support their rare hematology franchise, ensuring alignment with the market’s needs.